Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

33.6K
Overview
33.6K
Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the landscape of individual-based models for respiratory pathogen transmission in the pandemic and post-pandemic era (2020-2024): A systematic review.

Epidemics·2026
Same author

Stillbirth and newborn data quality and use and related input and process factors: findings of the IMPULSE study in Uganda.

Journal of global health·2026
Same author

Exploring the Socio-Economic Toll of Non-Communicable Diseases in Low-Resource Settings: Novel Evidence From Mozambique.

The International journal of health planning and management·2026
Same author

Global approaches to infectious disease surveillance and modeling.

Nature medicine·2026
Same author

Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach.

medRxiv : the preprint server for health sciences·2026
Same author

Household and community-based approaches to malaria and cholera prevention: A narrative review with case studies from Uganda and Mozambique.

PLoS neglected tropical diseases·2026
Same journal

Flubendazole 2.0: Designing a large field trial in dogs for a challenging setting.

PLoS neglected tropical diseases·2026
Same journal

Temporal and spatial patterns of Leprosy in Uganda, 2020-2024: A nationwide surveillance analysis.

PLoS neglected tropical diseases·2026
Same journal

Prevalence and risk factors of asymptomatic Plasmodium spp. infection in the military population of the Colombian National Army.

PLoS neglected tropical diseases·2026
Same journal

Mobility and non-household environments: Understanding dengue transmission patterns in urban contexts.

PLoS neglected tropical diseases·2026
Same journal

Hantavirus stability and inactivation.

PLoS neglected tropical diseases·2026
Same journal

Disability as a neglected outcome of neglected tropical diseases: A systematic review.

PLoS neglected tropical diseases·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Containing Ebola at the Source with Ring Vaccination.

Stefano Merler1, Marco Ajelli1, Laura Fumanelli1

  • 1Bruno Kessler Foundation, Trento, Italy.

Plos Neglected Tropical Diseases
|November 3, 2016
PubMed
Summary
This summary is machine-generated.

Ring vaccination with the rVSV-ZEBOV vaccine shows high efficacy against Ebola virus disease. This strategy, combined with improved healthcare readiness, can contain outbreaks even with higher transmission rates.

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.4K

Related Experiment Videos

Last Updated: Mar 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.4K

Area of Science:

  • Epidemiology
  • Infectious Disease Modeling
  • Vaccinology

Background:

  • Ebola virus disease (EVD) outbreaks pose significant public health challenges.
  • Ring vaccination strategies, targeting contacts of index cases, have shown promise in controlling EVD.
  • The rVSV-ZEBOV vaccine has demonstrated high efficacy in interim trial results.

Purpose of the Study:

  • To numerically estimate the effectiveness of ring vaccination strategies for EVD containment.
  • To identify key healthcare system parameters that influence outbreak containment success.
  • To assess the impact of combined interventions on controlling EVD outbreaks.

Main Methods:

  • Development of a spatially explicit agent-based model simulating EVD outbreaks.
  • Modeling was conducted for the Pujehun district in Sierra Leone.
  • Sensitivity analysis was performed on healthcare system parameters and intervention strategies.

Main Results:

  • Ring vaccination alone can contain outbreaks when the effective reproduction number (R0) is up to 1.6.
  • Improved contact tracing (2-3 days from symptom onset to hospitalization), expanded vaccination rings (2km), and reduced mobility (quarantines) can increase containment capacity.
  • These combined interventions can potentially contain outbreaks with an R0 up to 2.6.

Conclusions:

  • Ring vaccination is a viable strategy for controlling EVD outbreaks.
  • Enhancing healthcare system readiness and implementing complementary interventions significantly boosts containment capabilities.
  • Findings have implications for controlling future EVD and other emerging infectious disease threats.